Delivery Order SPE2DB24D2101-SPE2DB25FKNUS
- Not listed
- The Defense Logistics Agency awarded a $1,379.80 delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on August 6, 2025, with an ultimate completion date of August 7, 2025. This firm fixed-price contract represents a non-competitive delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $3,449.50 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on September 12, 2025, with an ultimate completion date of September 15, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. TYPHIM VI is a typhoid vaccine used for immunization against Salmonella typhi, reflecting the...
- The Defense Logistics Agency awarded a delivery order valued at $13,798.00 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on August 20, 2025, with a completion date of August 21, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. TYPHIM VI is a typhoid vaccine used for immunization against typhoid fever, supporting military and federal healthcare requirements. The work will be performed at...
- The Defense Logistics Agency awarded a $13,798.00 delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes, with an ultimate completion date of August 20, 2025. This firm fixed-price contract, awarded on August 19, 2025, utilizes a competitive delivery order mechanism with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TYPHIM VI is a typhoid vaccine product, reflecting the Defense...
- The Defense Logistics Agency awarded a $6,899.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on August 14, 2025, with an ultimate completion date of August 15, 2025. This non-competitive delivery order was placed against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. The work...
- The Defense Logistics Agency awarded a delivery order valued at $3,162.72 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on August 20, 2025, with a completion date of August 21, 2025. This firm fixed-price delivery order is non-competitive and utilizes no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this pharmaceutical supply contract. The award represents a child delivery order under...
- The Defense Logistics Agency awarded a delivery order valued at $15,923.04 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on September 5, 2025, with completion targeted for September 8, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. TYPHIM VI is a typhoid vaccine product commonly used in military and federal healthcare settings...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for TYPHIM VI 25 MCG/0.5 ML syringes valued at $1,379.80 with a firm fixed price structure. This is a non-set-aside, competitively awarded contract with performance scheduled for completion by July 25, 2025, at AmerisourceBergen's facility in Conshohocken, Pennsylvania. TYPHIM VI is a typhoid vaccine used by the Department of Defense for military personnel and beneficiaries requiring...
- The Defense Logistics Agency awarded a $3,825.30 delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 mcg/0.5 mL syringes on June 25, 2025, with completion expected by June 26, 2025. The contract utilizes a firm fixed price structure with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $6,899 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on August 27, 2025, with an ultimate completion date of August 28, 2025. This competitively awarded, firm fixed-price contract requires no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TYPHIM VI is a typhoid conjugate vaccine commonly used for military personnel and federal...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKNUSDelivery Order
The Defense Logistics Agency awarded a $10,934.71 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes, with an ultimate completion date of August 25, 2025. This non-competitive delivery order was issued under the company's existing indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. The product will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. TYPHIM VI is a typhoid vaccine used for immunization against typhoid fever, particularly relevant for military personnel and Department of Defense beneficiaries requiring preventive healthcare. This delivery order exemplifies AmerisourceBergen's role as a critical pharmaceutical vendor within the military supply chain, supporting the Defense Health Agency and other federal healthcare systems through its prime vendor contract that enables flexible procurement of vaccines, medications, and medical supplies across multiple therapeutic categories. The award reflects the company's established capability to meet federal medical procurement requirements through its existing IDC vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.9k | 8/22/25 |